-
How has Shire changed over the last five years? What was once the 'ADHD company' has now become one of the world’s most successful specialty biopharmaceutical companies. An operation covering only nine markets now extends to 28, with more coming soon. A pipeline with great potential has become one that's delivering solid results, and a narrow research focus has expanded into leading-edge expertise in pioneering technologies like human cell line biologics and Carrierwave technology.
-
Any other company would be talking about 'transformation', and in many ways that's the right word to use. But for Shire, this is just another stage in a continuous process that started over ten years ago. We've built this company by turning foresight into insight- in other words, by identifying the emerging trends in our sector, and having the courage to act on that knowledge. We saw the opportunity for specialty pharmaceuticals, and moved quickly to occupy that space.We predicted the impact of generics, and the growing pressure on drug pricing, and made sure we had the pipeline and business model to deal with it.
-
The same thing is happening now: We can see the big pharma model has outlived its useful life, and we continue to position Shire to take full advantage of the new trends that will shape our industry over the next decade. And just as before, this will be about practical, effective decision-making that builds momentum and keeps us ahead of the curve. So yes, we've transformed this company out of all recognition, but we prefer to see it as what we do every day: Raising the bar ever higher for Shire.
-
We've built Shire into one of the most successful specialty biopharmaceutical companies in the world by delivering solid returns for our shareholders, and helping people with life-altering conditions lead better lives. We do that by meeting the needs of specialist physicians, treating symptomatic diseases, and identifying and addressing niche unmet needs. Our business model has proved to be robust, resilient and right for the future, and it's allowed us to evolve industry-leading products, capabilities, and expertise.
